Aimei Health Technology Co., Ltd (AFJK) 은(는) 상장 기업입니다 금융 섹터의 Shell Companies 산업에서 운영. 본사 소재지는 New York City, NY, 미국. 현재 CEO는 Junheng Xie.
AFJK 을(를) 보유 IPO 날짜 2024-01-22, 2 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $313.43M.
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
